Science Talks // An Educational Webinar Series for Journalists organized with Wiley

In situations when reporters are uncertain about sources or interpreting the science is where the World Federation of Science Journalists (WFSJ) can help! The WFSJ provides ongoing training and support for new and seasoned reporters around the world. In partnership with Wiley, we are pleased to introduce to 10,000 science journalists globally and to everyone who is interested in a new series of webinars called Science Talks that are brought to you by The Wiley Network.


  • Tuesday 18 March on Trends in Sustainable Agriculture
  • Monday 22 April on Artificial Intelligence:


Science Talks webinars are complimentary to WFSJ members and other science journalists interested in the subject. If you are not able to attend the live one-hour session the webinars will be recorded for later viewing on the WFSJ website. You can register here for:



Science Talks with the Society for Applied Microbiology

Summary :

Media interested in learning more about Antimicrobial Resistance to inform their reporting should attend. Participants will walk away with a deeper understanding of:

    • A brief history of antimicrobial resistance (AMR) and how it occurs.
    • What are the leading causes of microbes/bacteria becoming resistant to drug treatments?
    • What threat does antimicrobial resistance pose to humans?
    • How are scientists fighting back against antimicrobial resistance?
    • AMR expert sources to use in news stories
    • Treatment options available now and in the future

NOTE: Science Talks webinars are recorded for on-demand viewing.

The speakers:

  • Dr. Lucy Harper, Chief Executive of The Society for Applied Microbiology
  • Dr. Mark Fielder, President od The Society for Applied Microbiology


Our hosts for this 3rd Science Talks organized with Wiley Publishers were Dr. Kenneth Mayer and Dr. Annette Sohn from the International AIDS Society 

Media who view/review this webinar will learn more about:

• A brief history of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS)
• What regions are most affected by HIV/AIDS, areas with an uptick in reported cases and the reasons for regional disparities
• How countries respond to the epidemic and the most effective tactics being used in the fight against HIV and AIDS
• Why the current approach to confronting the HIV/AIDS epidemic is drawing criticism; who are those critics and what is their impact on prevention and treatment options
• What treatments are available now and in the future
• Which sources of information are most reliable for journalists reporting on HIV and AIDS


Biographies of the three host speakers are available here.

#2nd WEBINAR: TACKLING EBOLA (24 July 2018)

View or review the webinar on Tackling Ebola

The second Science Talk on tackling Ebola took place on Tuesday 24 July at 11:00 am EST. In this session, Dr. Peter Halfmann, Research Associate Professor at the Influenza Research Institute at the University of Wisconsin, discussed the latest facts and figures on this infectious disease including news about vaccines.

Attendees learned more about:

  • The current situation in regions affected by the Ebola virus and if there is still any danger.
  • Where we stand with the research on finding a vaccine and if the latest human trials were successful.
  • When the vaccine will be made available for humans affected in regions by the Ebola virus.
  • What the future will bring in terms of infectious diseases, such as Ebola.
  • How local journalists can better report on infectious diseases including what they should look for, what kind of questions to ask, what resources they should use.


View or review our first webinar here. 

The first webinar, Science Talks with Cochrane took place on Tuesday, 22 May 2018 at 11:00 am ET.

In this session, Power of the Media – How to Translate Cochrane Health Evidence to Inform the Public, media learned:

  • How to use the Cochrane Library to support news stories covering important health subjects;
  • What sets Cochrane evidence aside from other types of health-related studies;
  • Why Cochrane evidence has rigorous quality standards;
  • The role of media in helping to translate medical evidence to help consumers make informed health decisions.

Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health.

Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. These are called systematic reviews.

Cochrane is a not-for-profit organization with collaborators from more than 130 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Our work is recognized as representing an international gold standard for high quality, trusted information. Find out more at Follow us on twitter @cochranecollab.


About The Wiley Network

Wiley believes the most successful individuals never stop learning. The Wiley Network draws on trusted Wiley authors, partners, and subject matter experts as well as professional leaders to share their knowledge and experiences to support learning and professional growth. Explore contributions from industry thought-leaders—from those with years of experience to those just starting out. Take advantage of white papers, infographics, interviews, opinion pieces, industry updates, videos, and more to help you stay ahead of the changing world. Customize your experience on The Wiley Network site by selecting your favourite subjects and interests.

About Wiley

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at